Jerry Lee, Md, Msc, Mphil

This study is testing a new treatment combination for adults newly diagnosed with hemophagocytic lymphohistiocytosis (HLH), a rare and severe condition where the immune system attacks the body. Researchers want to see if adding the drug ruxolitinib to a reduced-dose version of st…